Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04167384 · ClinicalTrials.gov registry record · NA
CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT04167384 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 69 participants.
The verdict
NCT04167384, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This is a two-arm, single use, single-center, randomized, 10-sequence per arm, open-label, crossover pharmacokinetic/pharmacodynamic (PK/PD) study, designed to evaluate elements of abuse liability (AL) including subjective effects, plasma nicotine uptake, and physiological measures during and following ad libitum use of the study investigational products (IPs) by generally healthy subjects.
Interventions
- OTHER Product A
- OTHER Product B
- OTHER Product C
- OTHER Product D
- OTHER Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04167384
The ClinicalTrials.gov registry entry for NCT04167384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.
NCT04167384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04167384 about?
NCT04167384 is a clinical study titled "CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products". This is a two-arm, single use, single-center, randomized, 10-sequence per arm, open-label, crossover pharmacokinetic/pharmacodynamic (PK/PD) study, designed to evaluate elements of abuse liability (AL) including subjective effects, plasma nicotine uptake, and physiological measures during and follow...
What is the current status of trial NCT04167384?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2019-12-02. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT04167384?
The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).
Who is sponsoring clinical trial NCT04167384?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.